This report analyzes the worldwide markets for Bioabsorbable Stents in Thousand Units. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2018. The report profiles 16 companies including many key and niche players such as Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, BIOTRONIK SE & Co. KG, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., and REVA Medical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.